$CLVS Clovis Oncology, Inc. Insider Trading
Get free email notifications about insider trading in Clovis Oncology, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Clovis Oncology, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Clovis Oncology, Inc. for free.
CIK Number: 0001466301
IRS Number: 900475355
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: CLVS
Company Address: 5500 FLATIRON PARKWAY SUITE 100 BOULDER 80301
Phone number: (303) 625-5000
Market Capitalization: $2.45B
Prev close: $60.00
Average Daily Volume: 2,294,270
Days Low: $58.72
Year Low: $11.57
Year High: $67.16
Clovis Oncology, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 11 2021 | CLVS | Clovis Oncology, I ... | SPICKSCHEN THORLEF | Director | Option Exercise | A | 5.97 | 42,223 | 252,071 | 42,223 | |
Jun 11 2021 | CLVS | Clovis Oncology, I ... | Azelby Robert | Director | Option Exercise | A | 5.97 | 42,223 | 252,071 | 42,223 | |
Jun 11 2021 | CLVS | Clovis Oncology, I ... | KLINGENSTEIN PAUL H | Director | Option Exercise | A | 5.97 | 42,223 | 252,071 | 42,223 | |
May 04 2021 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 4,625 | 0 | 50,875 | |
May 04 2021 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 3,749 | 0 | 26,245 | |
May 04 2021 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 5.54 | 2,183 | 12,094 | 249,501 | 251.7 K to 249.5 K (-0.87 %) |
May 04 2021 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 4,625 | 0 | 251,684 | 247.1 K to 251.7 K (+1.87 %) |
May 04 2021 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 5.54 | 1,769 | 9,800 | 247,059 | 248.8 K to 247.1 K (-0.71 %) |
May 04 2021 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 3,749 | 0 | 248,828 | 245.1 K to 248.8 K (+1.53 %) |
May 04 2021 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Option Exercise | M | 0.00 | 4,625 | 0 | 50,875 | |
May 04 2021 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Option Exercise | M | 0.00 | 5,623 | 0 | 39,367 | |
May 04 2021 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Sell | S | 5.54 | 1,448 | 8,022 | 54,977 | 56.4 K to 55 K (-2.57 %) |
May 04 2021 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Buy | M | 0.00 | 3,067 | 0 | 56,425 | 53.4 K to 56.4 K (+5.75 %) |
May 04 2021 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Sell | S | 5.54 | 1,206 | 6,681 | 53,358 | 54.6 K to 53.4 K (-2.21 %) |
May 04 2021 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Buy | M | 0.00 | 2,556 | 0 | 54,564 | 52 K to 54.6 K (+4.91 %) |